Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency

Nanis S Marzuki, Firman P Idris, Hannie D Kartapradja, Alida R Harahap, Jose R L Batubara, Nanis S Marzuki, Firman P Idris, Hannie D Kartapradja, Alida R Harahap, Jose R L Batubara

Abstract

The 5-alpha-reductase type 2 deficiency (5ARD2) is an autosomal recessive condition associated with impairment in the conversion of testosterone to dihydrotestosterone. This condition leads to undervirilisation in 46,XY individuals. To date, there have been more than 100 variations identified in the gene responsible for 5ARD2 development (steroid 5-alpha-reductase 2, SRD5A2). However, few studies have examined the molecular characterisation of Indonesian 5ARD2 cases. In the current study, we analysed 37 subjects diagnosed with 46,XY DSD (disorders of sex development) with confirmed variations in the SRD5A2 gene. We examined results from testosterone/dihydrotestosterone (T/DHT) and urinary etiocholanolone/androsterone (Et/An) ratios, as well as from molecular and clinical analyses. Twelve variants in the SRD5A2 gene were identified, and 6 of which were novel, namely, c.34-38delGinsCCAGC, p.Arg50His, p.Tyr136 , p.Gly191Arg, p.Phe194Ile, and p.Ile253Val variants. Moreover, we determined that 20 individuals contained harmful mutations, while the remaining 17 variants were benign. Those containing harmful mutations exhibited more severe phenotypes with median external genitalia masculinisation scores (EMS) of 3 (1.5-9) and were more likely to be diagnosed at a later age, reared as female, and virilised at pubertal age. In addition, the respective sensitivities for detecting severe 5ARD2 cases using T/DHT (cutoff: 10) and urinary Et/An ratios (cutoff: 0.95) were 85% and 90%, whereas mild cases were only identified with 64.7% and 47.1% sensitivity, respectively. Although we were unable to identify clear correlations between genotypic and phenotypic characteristics in this study, we clearly showed that individuals who were homozygous or compound heterozygous for any of the harmful mutations were more likely to exhibit classic 5ARD2 phenotypes, lower EMS, female assignment at birth, and virilisation during puberty. These results serve to inform the development of improved clinical and molecular 5ARD2 diagnostic approaches, specifically in Indonesian patients.

Conflict of interest statement

The authors have no personal or financial conflicts of interest to declare.

Copyright © 2019 Nanis S. Marzuki et al.

Figures

Figure 1
Figure 1
Distribution of the SRD5A2 gene variants identified in 37 cases of 48,XY DSD. Most of the variants are located at exons 1 and 4 of the SRD5A2 gene.
Figure 2
Figure 2
The geographical distribution of the identified SRD5A2 gene variants as determined by the ancestral place of origin for each participant. Transparent boxes indicate major islands in Indonesia; white boxes indicate SRD5A2 gene variations based on subjects' ethnic origins. Acehnese, Batak, and Malay are originated from Sumatera island; the Sundanese, Betawi, and Javanese reside in Java island; and Buginese and Toraja are from South Celebes. The Indonesian Chinese people reside in almost all of Indonesian islands, especially in the major islands. White dot (◦) indicates Jakarta, the capital city of Indonesia.

References

    1. Wilson J. D., Griffin J. E., Russell D. W. Steroid 5 alpha-reductase 2 deficiency. Endocrine Reviews. 1993;14(5):577–593. doi: 10.1210/edrv-14-5-577.
    1. Imperato-McGinley J., Guerrero L., Gautier T., Peterson R. E. Steroid 5agr-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186(4170):1213–1215. doi: 10.1126/science.186.4170.1213.
    1. Cohen-Kettenis P. T. Gender change in 46,XY persons with 5α-reductase-2 deficiency and 17β-hydroxysteroid dehydrogenase-3 deficiency. Archives of Sexual Behavior. 2005;34(4):399–410. doi: 10.1007/s10508-005-4339-4.
    1. Walter K. N., Kienzle F. B., Frankenschmidt A., et al. Difficulties in diagnosis and treatment of 5α-reductase type 2 deficiency in a newborn with 46,XY DSD. Hormone Research in Paediatrics. 2010;74(1):67–71. doi: 10.1159/000313372.
    1. Bertelloni S., Scaramuzzo R. T., Parrini D., Baldinotti F., Tumini S., Ghirri P. Early diagnosis of 5α-reductase deficiency in newborns. Sexual Development. 2007;1(3):147–151. doi: 10.1159/000102103.
    1. Chan A. O. K., But B. W. M., Lee C. Y., et al. Diagnosis of 5-reductase 2 deficiency: is measurement of dihydrotestosterone essential? Clinical Chemistry. 2013;59(5):798–806. doi: 10.1373/clinchem.2012.196501.
    1. Perry R. J., Novikova E., Wallace A. M., Donaldson M. D. C. Pitfalls in the diagnosis of 5α-reductase type 2 deficiency during early infancy. Hormone Research in Paediatrics. 2011;75(5):380–382. doi: 10.1159/000324646.
    1. Marzuki N. S., Suciati L. P., Dewi M., Tridjaja B. Two novel mutations of SRD5A2 gene in Indonesian siblings with clinical 5-alpha-reductase deficiency. Journal of Pediatric Endocrinology and Metabolism. 2010;23(12):1329–1333. doi: 10.1515/jpem.2010.207.
    1. Ahmed S. F., Rodie M. Investigation and initial management of ambiguous genitalia. Best Practice & Research Clinical Endocrinology & Metabolism. 2010;24(2):197–218. doi: 10.1016/j.beem.2009.12.001.
    1. Miller S., Dykes D., Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research. 1988;16(3):p. 1215. doi: 10.1093/nar/16.3.1215.
    1. Nie M., Zhou Q., Mao J., Lu S., Wu X. Five novel mutations of SRD5A2 found in eight Chinese patients with 46,XY disorders of sex development. Molecular Human Reproduction. 2011;17(1):57–62. doi: 10.1093/molehr/gaq072.
    1. Makridakis N. M., Di Salle E., Reichardt J. K. V. Biochemical and pharmacogenetic dissection of human steroid 5?-Reductase type II. Pharmacogenetics. 2000;10(5):407–413. doi: 10.1097/00008571-200007000-00004.
    1. Gad Y. Z., Khairt R., Mazen I., Osman H. G. Detection of the G34R mutation in the 5 alpha reductase 2 gene by allele specific PCR and its linkage to the 89L allele among Egyptian cases. Sexual Development. 2007;1(5):293–296. doi: 10.1159/000108931.
    1. Avendaño A., Paradisi I., Cammarata-scalisi F., Callea M. 5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review. Hormones. 2018;17(2):197–204. doi: 10.1007/s42000-018-0013-9.
    1. Akcay T., Fernandez-cancio M., Turan S., Güran T., Audi L., Bereket A. ARandSRD5A2gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity. Andrology. 2014;2(4):572–578. doi: 10.1111/j.2047-2927.2014.00215.x.
    1. Vilchis F., Valdez E., Ramos L., García R., Gómez R., Chávez B. Novel compound heterozygous mutations in the SRD5A2 gene from 46,XY infants with ambiguous external genitalia. Journal of Human Genetics. 2008;53(5):401–406. doi: 10.1007/s10038-008-0274-2.
    1. Marchetti P. M., Barth J. H. Clinical biochemistry of dihydrotestosterone. Annals of Clinical Biochemistry. 2013;50(2):95–107. doi: 10.1258/acb.2012.012159.
    1. Thiele S., Hoppe U., Holterhus P.-M., Hiort O. Isoenzyme type 1 of 5alpha-reductase is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of 5alpha-reductase type 2 deficient males. European Journal of Endocrinology. 2005;152(6):875–880. doi: 10.1530/eje.1.01927.
    1. Imperato-McGinley J., Peterson R. E., Gautier T., et al. Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5α-reductase deficiency. The Journal of Clinical Endocrinology & Metabolism. 1982;54(5):931–941. doi: 10.1210/jcem-54-5-931.
    1. Ittiwut C., Pratuangdejkul J., Supornsilchai V., et al. Novel mutations of the SRD5A2 and AR genes in Thai patients with 46,XY disorders of sex development. Journal of Pediatric Endocrinology and Metabolism. 2016;30(1):19–26. doi: 10.1515/jpem-2016-0048.
    1. Fernández-Cancio M., Audí L., Andaluz P., et al. SRD5A2 gene mutations and polymorphisms in Spanish 46,XY patients with a disorder of sex differentiation. International Journal of Andrology. 2011;34(6pt2):e526–e535. doi: 10.1111/j.1365-2605.2010.01136.x.
    1. Cheng J., Lin R., Zhang W., et al. Phenotype and molecular characteristics in 45 Chinese children with 5α-reductase type 2 deficiency from South China. Clinical Endocrinology. 2015;83(4):518–526. doi: 10.1111/cen.12799.
    1. Samtani R., Bajpai M., Ghosh P. K., Saraswathy K. N. A49T, R227Q and TA repeat polymorphism of steroid 5 alpha-reductase type II gene and Hypospadias risk in North Indian children. Meta Gene. 2015;3:1–7. doi: 10.1016/j.mgene.2014.11.003.
    1. Sasaki G., Ogata T., Ishii T., et al. Micropenis and the 5α-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients. The Journal of Clinical Endocrinology & Metabolism. 2003;88(7):3431–3436. doi: 10.1210/jc.2002-021415.
    1. Thai H. T. T., Kalbasi M., Lagerstedt K., Frisén L., Kockum I., Nordenskjöld A. The valine allele of the V89L polymorphism in the 5-α-Reductase gene confers a reduced risk for hypospadias. The Journal of Clinical Endocrinology & Metabolism. 2005;90(12):6695–6698. doi: 10.1210/jc.2005-0446.
    1. Maimoun L., Philibert P., Cammas B., et al. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients. The Journal of Clinical Endocrinology & Metabolism. 2011;96(2):296–307. doi: 10.1210/jc.2010-1024.
    1. Makridakis N. M., Ross R. K., Pike M. C., et al. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. The Lancet. 1999;354(9183):975–978. doi: 10.1016/s0140-6736(98)11282-5.
    1. Shabir I., Khurana M. L., Joseph A. A., Eunice M., Mehta M., Ammini A. C. Phenotype, genotype and gender identity in a large cohort of patients from India with 5α-reductase 2 deficiency. Andrology. 2015;3(6):1132–1139. doi: 10.1111/andr.12108.
    1. Kamrath C., Wudy S. A., Krone N. Steroid biochemistry. In: Hiort O., Ahmed S. F., editors. Endocrine Development. Vol. 27. Basel, Switzerland: Karger; 2014. pp. 41–52.
    1. Bertelloni S., Russo G., Baroncelli G. I. Human chorionic gonadotropin test: old uncertainties, new perspectives, and value in 46,XY disorders of sex development. Sexual Development. 2018;12(1–3):41–49. doi: 10.1159/000481552.
    1. Taieb J. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clinical Chemistry. 2003;49(8):1381–1395. doi: 10.1373/49.8.1381.
    1. Kulle A., Krone N., Holterhus P. M., et al. Steroid hormone analysis in diagnosis and treatment of DSD: position paper of EU COST Action BM 1303 “DSDnet”. European Journal of Endocrinology. 2017;176(5):P1–P9. doi: 10.1530/eje-16-0953.
    1. Berra M., Williams E. L., Muroni B., et al. Recognition of 5α-reductase-2 deficiency in an adult female 46XY DSD clinic. European Journal of Endocrinology. 2011;164(6):1019–1025. doi: 10.1530/eje-10-0930.
    1. Walsh P. C., Madden J. D., Harrod M. J., Goldstein J. L., MacDonald P. C., Wilson J. D. Familial incomplete male pseudohermaphroditism, type 2. New England Journal of Medicine. 1974;291(18):944–949. doi: 10.1056/nejm197410312911806.
    1. Thigpen A. E., Davis D. L., Gautier T., Imperato-McGinley J., Russell D. W. The molecular basis of steroid 5α-reductase deficiency in a large dominican kindred. New England Journal of Medicine. 1992;327(17):1216–1219. doi: 10.1056/nejm199210223271706.
    1. Imperato-McGinley J., Miller M., Wilson J. D., Peterson R. E., Shackleton C., Gajdusek D. C. A cluster of male pseudohermaphrodites with 5α-reductase deficiency in Papua New Guinea. Clinical Endocrinology. 1991;34(4):293–298. doi: 10.1111/j.1365-2265.1991.tb03769.x.
    1. Hochberg Z., Chayen R., Reiss N., et al. Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5 alpha-reductase 2 deficiency. The Journal of Clinical Endocrinology & Metabolism. 1996;81(8):2821–2827. doi: 10.1210/jcem.81.8.8768837.
    1. Akgun S., Ertel N. H., Imperato-McGinley J., Sayli B. S., Shackleton C. Familial male pseudohermaphroditism due to 5-alpha-reductase deficiency in a Turkish village. The American Journal of Medicine. 1986;81(2):267–274. doi: 10.1016/0002-9343(86)90262-7.
    1. Canto P., Vilchis F., Chávez B., et al. Mutations of the 5α-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5α-reductase-2 deficiency. Clinical Endocrinology. 1997;46(2):155–160. doi: 10.1046/j.1365-2265.1997.800904.x.
    1. Nordenskjöld A., Ivarsson S.-A. Molecular characterization of 5α-reductase type 2 deficiency and fertility in a Swedish family 1. The Journal of Clinical Endocrinology & Metabolism. 1998;83(9):3236–3238. doi: 10.1210/jcem.83.9.5125.

Source: PubMed

3
Prenumerera